Viral hepatitis B is an infectious liver disease transmitted through blood and other body fluids. The primary challenge remains low detection rates: the infection can be asymptomatic or present with subtle clinical symptoms, leading to significant delays in diagnosis.
According to WHO data (2022), only 13% of infected individuals are aware of their diagnosis, and only 3% receive the necessary therapy.